Roger Aston

Dr Roger Aston is one of the most experienced and commercially astute people in drug commercialisation in Australia. He has more than 20 years' experience in the pharmaceutical and healthcare industries in senior roles in the United Kingdom, Asia-Pacific and Australia. Dr Aston is the chief executive of PharmAust's wholly owned subsidiary, Pitney Pharmaceuticals. He was chief executive of Mayne Pharma Group until 15 February 2012. Dr Aston is both a scientist and seasoned biotechnology entrepreneur, with a successful track record in both fields. Dr Aston holds a BSc (Hons) and PhD degrees from the University of Manchester from 1975 to 1981.
Bio last updated 04 Jun 2018

Article Timeline

Access to our data for Roger Aston is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Roger Aston is linked to 7 organisations which are included in 2 lists - Public Companies - Industrial and Technology Companies.

To see the data you will need to .

Total Shareholder Return as at 31/05/19

1 year TSR5 year TSR
193rdTransaction Solutions International17%12%
738thRewardle Holdings-67%
728 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Non-Executive Chairman
Non-Executive Director (Non-Executive Chair 2015-2017, Executive Chair 2013-2015)
Executive Chair (Acting CEO since May 2018)
Year started and most recent title


106th↑Rewardle Holdings$2.6m
110th↑Transaction Solutions International$2.3m
197 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer